Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-25-000144
Filing Date
2025-08-27
Accepted
2025-08-27 08:25:26
Documents
1
Period of Report
2025-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1756297522.html 4  
1 FORM 4 wk-form4_1756297522.xml 4 4009
  Complete submission text file 0001824293-25-000144.txt   5662
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Issuer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2223 AVIENDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address
Hertz Walter Marc (Reporting) CIK: 0001971132 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 251259914